Tamieka Lauz

Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.

Robin L. Jones, O. Mir, W. Tap, 2020, The Lancet. Oncology.